BAT Reports 2022 H2 Trading Update with Vuse and glo Growth

Dec.08.2022
BAT Reports 2022 H2 Trading Update with Vuse and glo Growth
British American Tobacco's 2022 update shows a 2-4% increase in revenue and Vuse's 35.7% global e-cigarette market share.

On December 8, 2022, British American Tobacco (referred to as BAT hereafter) released its trading update for the second half of the year on its official website. According to BAT, its income has increased by 2% to 4% based on fixed exchange rates up to 2022. Between September and now in 2022, Vuse's global market share has increased by 2.2 percentage points, reaching 35.7% in major global e-cigarette markets, compared to the 2021 fiscal year. BAT CEO Jack Bowles said, "Our new categories business continues to drive strong sales, revenue, and market share growth and has become an important contributor to the group's performance." The key points of this trading update were found by 2FIRSTS.


The image is sourced from the official website of BAT's Vuse.


Compared to the 2021 fiscal year, Vuse has seen an increase of 2.2 percentage points in global market share from September to present, reaching 35.7% in major e-cigarette markets. Vuse has solidified its position as the leader in the US and is leading in 35 states, with a total market share of 39.3% and an increase of 6.8 percentage points from September to present. Disposable e-cigarettes continue to experience strong growth. The recently launched Vuse Go has reached second place in market share in the UK and France. Vuse Go is being rapidly promoted and has now been launched in 12 markets.


Glo continues to gain market share in its product category.


From September to present, the sales share of major THP categories has increased by 1.6 percentage points to reach 19.5%. In Europe, glo's sales share has reached 20.4%, with a growth of 4.0 percentage points in September in major THP markets. In Japan, compared to the 2021 fiscal year, Hyper has driven glo's total nicotine sales share growth by 50 basis points, with a share of 7.3% since the beginning of the year. The sales share of the THP category has decreased by 1.0 percentage point to 20.2% since September, amidst fierce competition in the market. The early results of the launch of Hyper X2 in Japan in October are encouraging. It has recently been launched in 19 major markets worldwide, with plans for further expansion before the end of the year.


Velo's strong leadership position in Europe continues to exist, unlocking emerging markets.


In Europe, 69.1% of the oral nicotine market share is held by Velo. Through innovative products such as the Velo Mini and Velo Max series, Velo maintains a leading position in sales in 15 modern oral markets across Europe. However, the category sales share of the primary oral nicotine market has decreased by 4.1% compared to the 2021 fiscal year, largely due to market trends in the United States. BAT (British American Tobacco) continues to prioritize investments in the growing electronic cigarette category. Meanwhile, Velo has achieved over 40 million monthly sales in Pakistan, where it is now BAT's third-largest oral nicotine market, showing the potential for oral nicotine in emerging markets.


2FIRSTS will continue to report on this issue, with further updates available on the "2FIRSTS APP." Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spain’s Congress Health Committee has approved a non-binding motion calling for the sale of vapes, nicotine pouches, and related products to be limited to regulated authorized channels, excluding internet sales and non-specialized stores. The motion was introduced by the Socialist Parliamentary Group and approved after a negotiated text with the Popular Party.
Apr.15 by 2FIRSTS.ai
Cambodia Moves to Draft New Tobacco Control Strategy Targeting Illicit Products and E-Cigarette Spread
Cambodia Moves to Draft New Tobacco Control Strategy Targeting Illicit Products and E-Cigarette Spread
Cambodian Health Minister Cheang Ra has called for the development of a tobacco control strategy for 2027–2031, with the goal of reducing tobacco use by 30% by 2030. The directive was issued during a Tobacco Product Control Committee meeting in Phnom Penh. Priority areas include reducing tobacco use, protecting the public from secondhand smoke, tackling illegal and counterfeit tobacco products, and preventing the spread of e-cigarettes.
Apr.29 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
UK Bill Banning Tobacco Sales to People Born After 2008 Clears Parliament
UK Bill Banning Tobacco Sales to People Born After 2008 Clears Parliament
A UK bill banning the legal sale of tobacco to people born on or after January 1, 2009 has completed its passage through parliament. Under the bill, those born in that group will never be able to be legally sold tobacco anywhere in the UK. The legislation is expected to receive royal assent next week. It also gives ministers powers to strengthen public-place smoking restrictions and restricts branding, promotion and advertising of vape and nicotine products aimed at children.
Apr.22 by 2FIRSTS.ai
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
From May 8 to 10, 2026, Mylor (Booth E70) will exhibit at The Vaper Expo UK, where it will showcase its systematic experience design solutions for e-liquids. At present, the e-liquid market commonly faces a challenge: many products have “no obvious shortcomings, but lack memorable features.” In response, Mylor has proposed refined solutions across multiple dimensions, including device-adaptive sweetness, progressive cooling sensation, fruit-oriented sourness, and segmented nicotine experience.
May.08
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15